Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Eureka Therapeutics
company
About
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $45M
- Industries
- Biotechnology,Life Science,Medical,Medical Device,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. The company's platform is a novel T-cell therapy construct that mimics the natural biology of T-cells to fight cancer. It utilizes a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens.Eureka Therapeutics was founded in 2006 and is headquartered in Emeryville, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
Eureka Therapeutics has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
Mar 17, 2020 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 17, 2020 | Series E | $45M | 1 |
Lyell Immunopharma
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Eureka Therapeutics is funded by 1 investors.
Lyell Immunopharma
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lyell Immunopharma
|
Yes | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
